Protein discovery paves way for new multiple myeloma treatments
Multiple myeloma patients with the poorest prognosis are set to benefit from promising new research at Flinders University which seeks to find new treatments by targeting a protein on the surface of the cancer cells in the bone marrow.
Together with co-investigators Professors Claudine Bonder and Stuart Pitson from UniSA, Dr Wallington-Beddoe, who is also Head of Myeloma and Amyloidosis Services and Director of Haematology Clinical Trials at Flinders Medical Centre, recently discovered the presence of the DSG2 protein biomarker in some multiple myeloma patients.
He’s since found that about 20-30 per cent of newly diagnosed patients express the protein, with this group three times more likely to die within six years of diagnosis.
Dr Wallington-Beddoe and his co-investigators have been awarded a $130,000 research grant co-funded by Flinders Foundation and The Hospital Research Foundation to quickly identify newly diagnosed multiple myeloma patients who express the DSG2 protein, so they can be given the most appropriate, currently available therapies right away, whilst also searching for new treatments.
This support was made possible thanks to your generous donations to Flinders Foundation’s Multiple Myeloma appeal and from fundraisers in the community. Thank you.
Armed with this knowledge, Dr Wallington-Beddoe said the focus was now firmly on improving the prognosis for these high-risk patients by developing an antibody therapy to help manipulate the immune system to attack the cancer cells that express the protein.
“Multiple myeloma is a really hard cancer to treat at the best of times, even today it’s deemed incurable,” – Dr Wallington-Beddoe
“So, knowing about this protein and eventually having novel therapies to target it – it’s going to be a completely new playing field.”
Dr Wallington-Beddoe hopes early stage clinical trials on new therapies targeting this protein could be a reality at Flinders within five years.
“This is a big step in the right direction as the protein opens up a whole new therapeutic approach to patient specific medicine,” he says.
“And it’s such an area of need to have better therapies to treat myeloma patients that not only kill the cancer cells effectively but also minimise harmful side effects of the therapies themselves.
“My patients often ask me when we’re going to cure multiple myeloma. We’re certainly not there yet, but the approaches we are using are improving the outcomes of patients year by year.
“There’s immense hope that we can push it back more and more so that while we might not necessarily ‘beat’ it right way, we’ll push it back enough so that people can live longer and more productive lives ‘with’ it.”
You can support multiple myeloma research at Flinders by making a donation by clicking here, or phone the Flinders Foundation team on (08) 8204 5216.
This research has been co-funded by Flinders Foundation and The Hospital Research Foundation
Jane’s Wish – the Jane Watson Ramsey PhD Scholarship in Multiple Myeloma Research
Ali Habib, recipient of the inaugural Jane Watson Ramsey PhD Scholarship in Multiple Myeloma Research, says Jane and Bill’s generosity is providing him with the opportunity to make a difference for people living with the incurable disease.
The Ryan Hodges Scholarship in Precision Dosing
The Ryan Hodges Scholarship in Precision Dosing has been established in memory of Ryan, who passed away in October 2021.
Giving hope to people with brain cancer
Often, by the time a person is diagnosed with brain cancer, it’s too late to cure them.
Flinders Foundation welcomes Linda Williams APM to Board of Directors
The Chair of Flinders Foundation Alan Young AM is pleased to announce that South Australia Police (SAPOL) Deputy Commissioner Linda Williams APM has joined Flinders Foundation’s Board of Directors.
Bespoke cameras keeping newborn babies, families connected
New bespoke camera technology will provide comfort and reduce stress for families of premature babies in the Flinders Medical Centre Neonatal Unit.
Flinders researchers receive prestigious awards
Flinders University researchers Dr Yee Lian Chew and Dr Ash Hopkins have been recognised for their research excellence and enthusiasm for science communication, named in the Young Tall Poppy Science Awards for 2021.
Meet the new Cancer Wellness Centre Project Manager
There is a new, smiling face to greet patients and families at the Cancer Wellness Centre at Flinders Medical Centre.
Improving the lives of children with glaucoma
Thanks to generous supporters of eye health at Flinders, researchers are hoping to improve the lives of children with glaucoma by identifying genes which lead to more severe outcomes, while also focusing on methods to improve quality of life for patients, and their families.
Drakes Supermarkets giving patients with advanced cancers the best chance of survival
Drakes Supermarkets are giving patients with advanced cancers the best chance of survival and precious time to spend with their loved ones.
Mary Overton Fellowship: Worms the key to understanding brains
New research at Flinders is using tiny worms to understand how human brains learn, with hopes of helping those with chronic pain and neurodegenerative disorders.